These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia. Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307 [TBL] [Abstract][Full Text] [Related]
10. FOXO transcription factors in cancer development and therapy. Coomans de Brachène A; Demoulin JB Cell Mol Life Sci; 2016 Mar; 73(6):1159-72. PubMed ID: 26686861 [TBL] [Abstract][Full Text] [Related]
11. PI3K/Akt and MAPK pathways evoke activation of FoxO transcription factor to undergo neuronal apoptosis in brain of the silkworm Bombyx mori (Lepidoptera: Bombycidae). Kim JH; Choi JS; Lee BH Cell Mol Biol (Noisy-le-grand); 2012 Oct; Suppl.58():OL1780-5. PubMed ID: 23046871 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Zhao S; Konopleva M; Cabreira-Hansen M; Xie Z; Hu W; Milella M; Estrov Z; Mills GB; Andreeff M Leukemia; 2004 Feb; 18(2):267-75. PubMed ID: 14628071 [TBL] [Abstract][Full Text] [Related]
13. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Kharas MG; Okabe R; Ganis JJ; Gozo M; Khandan T; Paktinat M; Gilliland DG; Gritsman K Blood; 2010 Feb; 115(7):1406-15. PubMed ID: 20008787 [TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation. Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665 [TBL] [Abstract][Full Text] [Related]
16. Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways. Gao N; Budhraja A; Cheng S; Liu EH; Chen J; Yang Z; Chen D; Zhang Z; Shi X Cell Death Dis; 2011 Apr; 2(4):e140. PubMed ID: 21472003 [TBL] [Abstract][Full Text] [Related]
17. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia. Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294 [TBL] [Abstract][Full Text] [Related]
18. Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK. Dai Y; Rahmani M; Pei XY; Khanna P; Han SI; Mitchell C; Dent P; Grant S Blood; 2005 Feb; 105(4):1706-16. PubMed ID: 15494423 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of FOXO1/3 promotes vascular calcification. Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413 [TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway. Lam CF; Yeung HT; Lam YM; Ng RK Leuk Res; 2018 May; 68():112-119. PubMed ID: 29609096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]